In this episode of "Rethink My Health," Dr. Gez Agolli and Diane Spiva from Progressive Medical Center in Atlanta dive into the transformative world of functional medicine weight loss solutions. This episode details the obesity epidemic and talks through the benefits of integrative weight loss, including GLP-1 medications.
Injection of the peptide Semaglutide (Wegovy) has been found to offer long-term weight control, even for the obese. The peptide has been used along with a diet and exercise program to control blood sugar levels in adults with type 2 diabetes when other medications did not work well enough. Semaglutide injection is also used to reduce the risk of a stroke, heart attack, or death in adults who have type 2 diabetes and to help control heart vessel diseases. It’s no wonder that in 2021 the FDA approved subcutaneous injections of Semaglutide for long-term weight loss- the first diet drug approved since 2014.
